Press Releases
Quinten identifies a combination of two synergistic markers that predicts a favorable response to treatment in triple-negative breast cancer
Quinten, a strategic and operational consulting company specializing in the evaluation of biomedical data in the pharmaceutical, biotechnology and cosmetic industries, today announces the identification of two discriminating biological marker candidates which are indicative of a favorable response...
Press Releases
Affymax and Takeda Announce a Nationwide Voluntary Recall of All Lots of OMONTYS® (peginesatide) Injection
Affymax, Inc. and Takeda Pharmaceutical Company Limited (Takeda) today have decided to voluntarily recall all lots of OMONTYS® (peginesatide) Injection to the user level as a result of new postmarketing reports regarding serious hypersensitivity reactions, including anaphylaxis, which...
Press Releases
Shimojani Licenses New Stroke Therapy from Niigata University
Shimojani LLC, a privately held biotech company, today announced that it has acquired an exclusive license from Niigata University for worldwide development and commercialization rights to an invention that has the potential to substantially reduce the risk of...
Press Releases
Sprig Health Offers Uninsured Individuals up to 50 percent Discounts on Health Care
The Affordable Care Act has already made certain health care services more accessible and affordable, but today's uninsured individuals still cannot afford the high cost of even the most basic health care services. Sprighealth.com offers a solution for...
Press Releases
CiToxLAB Group increases revenue by 25 per cent over full year of 2012
CiToxLAB, a leading CRO in the field of non-clinical research, announces today that the group’s consolidated revenue for 2012 reached EUR 78.4 million (USD 102 million approximately). This represents a 25 per cent increase compared with 2011. ...
Press Releases
Global pharmaceutical regulatory affairs specialist ELC Group launches Clinical Trials services
ELC GROUP, one of the fastest-growing providers of regulatory affairs consulting services, today announces the launch of a new Clinical Trials service for pharmaceutical customers worldwide. The new end-to-end service offering spans Bioavailability/Bioequivalence (BA/BE)...
Press Releases
Ricoh Europe: The Speed of Change is Healthcare’s Biggest Technology-led Headache
New data from a study sponsored by Ricoh1 shows that 92.5 per cent of healthcare, biotech and pharmaceutical executives have become more reliant on technology during the last three years. The majority of healthcare...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read